India Host Cell Protein Testing Market Research Report Information by Product Type (PCR-based assays, ELISA-based assays, mass spectrometry-based assays and others), by End User (Contract Research Organizations, Biopharmaceutical Companies, and Others) –

India Host Cell Protein Testing Market Research Report Information by Product Type (PCR-based assays, ELISA-based assays, mass spectrometry-based assays and others), by End User (Contract Research Organizations, Biopharmaceutical Companies, and Others) – Industry Forecast to 2032

It is projected that the India host cell protein testing market will grow at a robust rate of 99.12% over the course of the review year. During the biotherapeutic manufacturing process, the host organism produces contaminants relevant to the process called host cell proteins (HCPs). Numerous HCPs are eliminated from the final product during the purification procedure. These are the proteins that the organisms that make recombinant therapeutic proteins create or encode. Using cell culture and fermentation techniques, genetically altered prokaryotic or eukaryotic host cells create recombinant therapeutic proteins.

Major factors propelling the expansion of the India host cell protein market include the country's high demand for biologics and its increasing adoption of strict regulatory rules for the manufacture of biopharmaceuticals. But it's anticipated that problems with the test kits' efficacy and accuracy will impede the Indian market's expansion. Still, there are significant government initiatives and a growing number of biopharmaceutical sector start-ups in India, which are said to be opening profitable potential for the Indian market.

Market Segment Insight
The India host cell protein testing market has been divided into segments according to product type, including mass spectrometry-based tests, PCR-based assays, and ELISA-based assays. During the forecast period, which runs from 2023 to 2032, the Mass Spectrometry-Based Assays segment is expected to develop at the fastest rate, while the ELISA-Based Assays segment maintained the biggest market share in 2022.
The India host cell protein testing market has been divided into biopharmaceutical firms, contract research organizations, and others based on the End User.

Principal Players
Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Abcam Limited, Enzo Life Sciences, Inc., Cytiva, Cygnus Technologies, LLC, Rockland Immunochemicals, Inc., Biogenes GmbH, and Krishgen BioSystems are the major companies in the host cell protein testing market in India.